Added to YB: 2026-05-06
Pitch date: 2026-05-01
NRXS [neutral]
NeurAxis, Inc.
+1.84%
current return
Author Info
Microcap Opportunities is a community dedicated to finding the best opportunities in the MicroCap space for US and Canadian listings primarily. Sign up for the newsletter.
Company Info
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
Market Cap
$93.0M
Pitch Price
$8.15
Price Target
19.00 (+129%)
Dividend
N/A
EV/EBITDA
-12.56
P/E
-8.52
EV/Sales
24.78
Sector
Health Care Equipment and Supplies
Category
growth
Multibaggers, Turnarounds and Steady Eddies - NeurAxis, Inc.
NRXS (holding update): Q1 prelim rev $1.6M, +78% YoY, strongest growth ever on Cat I CPT billing; GM ~87.5%; cash $7.1M vs $6M burn. Billing lag slowed ramp vs model, but thesis intact. Catalysts: 4 new Medicaid MCO policies (+1.25M lives), going concern removal likely in 10-Q unlocking institutional buyers. Adding VA + Medicaid to Craig-Hallum 2027E → $16.8M rev, $15-$19 PT at 12-15x. M&A upside (BSX/MDT/JNJ) not modeled.
Read full article (1 min)